Previous Close | 15.92 |
1-Year Change | 75.14% |
6-Months Change | -28.19% |
3-Months Change | -20.87% |
Moving Avg (50d) | 18.502 |
Moving Avg (200d) | 20.104 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.18B |
Beta (3-Years) | 1.09 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -30.17% |
EPS (ttm) | -2.02 |
PE Ratio (ttm) | -7.88 |
Dividend Yield | % |
Asset Description: | Kura Oncology, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-11-18 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
11.393 | 11.729 | 11.952 | 12.287 | 12.846 | 13.404 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.